Nalaganje...
The aryl hydrocarbon receptor is required for induction of p21(cip1/waf1) expression and growth inhibition by SU5416 in hepatoma cells
The aryl hydrocarbon receptor (AhR) is a potential clinical target for cancer and autoimmune dysfunction. Identifying selective AhR modulators that produce desirable clinical outcomes represents an opportunity for developing new anti-cancer agents. Repurposing clinically-used drugs with established...
Shranjeno v:
| izdano v: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals LLC
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5421923/ https://ncbi.nlm.nih.gov/pubmed/28424418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16056 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|